본문 바로가기
KERD
논문KCI 등재

The Gut Microbiome: Human Health and Inflammatory Skin Diseases

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류피부과학

초록

The human microbiome is a rich environment consisting of bacteria, fungi and other commensal microorganisms of the gut, mucosa and skin. The functional role of the gut microbiome includes facilitation in metabolism of macronutrients, maturation of the immune system, and production of pro- or anti-inflammatory signaling molecules and peptides. The identification of these resident organisms has brought about a new understanding of disease processes. Nevertheless, more questions remain regarding the interactions within the microbiome, its interactions with the host, and its contributions to the pathophysiology of disease. The purpose of this review is to examine the existing medical literature to highlight the role of the gut microbiome in human health, also paying attention to its role in several inflammatory skin diseases, namely atopic dermatitis, psoriasis, and rosacea.

Abstract

The human microbiome is a rich environment consisting of bacteria, fungi and other commensal microorganisms of the gut, mucosa and skin. The functional role of the gut microbiome includes facilitation in metabolism of macronutrients, maturation of the immune system, and production of pro- or anti-inflammatory signaling molecules and peptides. The identification of these resident organisms has brought about a new understanding of disease processes. Nevertheless, more questions remain regarding the interactions within the microbiome, its interactions with the host, and its contributions to the pathophysiology of disease. The purpose of this review is to examine the existing medical literature to highlight the role of the gut microbiome in human health, also paying attention to its role in several inflammatory skin diseases, namely atopic dermatitis, psoriasis, and rosacea.

참고문헌 (69)

  1. Stokes JH, "The effect on the skin of emotional and nervous states III. Theoretical and practical consideration of a gastro-intestinal mechanism", AMA Arch Derm Syphilol, 22, pp.962~993 (1930)
  2. Huttenhower C, "Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
  3. Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
  4. Kolbert CP, "Ribosomal DNA sequencing as a tool for identification of bacterial pathogens", Curr Opin Microbiol, 2, pp.299~305 (1999)
  5. Chen K, "Bioinformatics for whole-genome shotgun sequencing of microbial communities", PLoS Comput Biol, 1, pp.106~112 (2005)
  6. O'Hara AM, "The gut flora as a forgotten organ", EMBO Rep, 7, pp.688~693 (2006)
  7. Tap J, "Towards the human intestinal microbiota phylogenetic core", Environ Microbiol, 11, pp.2574~2584 (2009)
  8. Jandhyala SM, "Role of the normal gut microbiota", World J Gastroenterol, 21, pp.8787~8803 (2015)
  9. De Filippo C, "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa", Proc Natl Acad Sci U S A, 107, pp.14691~14696 (2010)
  10. Turnbaugh PJ, "An obesity-associated gut microbiome with increased capacity for energy harvest", Nature, 444, pp.1027~1031 (2006)
  11. Jumpertz R, "Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans", Am J Clin Nutr, 94, pp.58~65 (2011)
  12. Turnbaugh PJ, "The effect of diet on the human gut microbiome : a metagenomic analysis in humanized gnotobiotic mice", Sci Transl Med, 1, pp.6ra14~ (2009)
  13. Cani PD, "Metabolic endotoxemia initiates obesity and insulin resistance", Diabetes, 56, pp.1761~1772 (2007)
  14. Andriessen EM, "Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization", EMBO Mol Med, 8, pp.1366~1379 (2016)
  15. Medzhitov R, "Origin and physiological roles of inflammation", Nature, 454, pp.428~435 (2008)
  16. Franceschi C, "Inflamm-aging : an evolutionary perspective on immunosenescence", Ann NY Acad Sci, 908, pp.244~254 (2000)
  17. Franceschi C, "Chronic inflammation(inflammaging)and its potential contribution to age-associated diseases", J Gerontol A Biol Sci Med Sci, 69(Suppl 1), pp.S4~S9 (2014)
  18. Jeffery IB, "Composition and temporal stability of the gut microbiota in older persons", ISME J, 10, pp.170~182 (2016)
  19. Biagi E, "Through ageing, and beyond : gut microbiota and inflammatory status in seniors and centenarians", PLoS One, 5, pp.e10667~ (2010)
  20. Boulangé CL, "Impact of the gut microbiota on inflammation, obesity, and metabolic disease", Genome Med, 8, pp.42~ (2016)
  21. Venkatesh M, "Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4", Immunity, 41, pp.296~310 (2014)
  22. Vinolo MA, "Regulation of inflammation by short chain fatty acids", Nutrients, 3, pp.858~876 (2011)
  23. Hansen JJ, "Therapeutic manipulation of the microbiome in IBD : current results and future approaches", Curr Treat Options Gastroenterol, 13, pp.105~120 (2015)
  24. Manichanh C, "Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach", Gut, 55, pp.205~211 (2006)
  25. Dommett R, "Innate immune defence in the human gastrointestinal tract", Mol Immunol, 42, pp.903~912 (2005)
  26. Jiménez E, "Is meconium from healthy newborns actually sterile?", Res Microbiol, 159, pp.187~193 (2008)
  27. Collado MC, "Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid", Sci Rep, 6, pp.23129~ (2016)
  28. Rautava S, "Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial", Neonatology, 102, pp.178~184 (2012)
  29. Bäckhed F, "Dynamics and stabilization of the human gut microbiome during the first year of life", Cell Host Microbe, 17, pp.690~703 (2015)
  30. Penders J, "Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR", FEMS Microbiol Lett, 243, pp.141~147 (2005)
  31. O'Sullivan A, "The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants", Nutr Metab Insights, 8(Suppl 1), pp.1~9 (2015)
  32. Garrido D, "Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria", Sci Rep, 5, pp.13517~ (2015)
  33. Dong P, "The role of intestinal bifidobacteria on immune system development in young rats", Early Hum Dev, 86, pp.51~58 (2010)
  34. Palmer C, "Development of the human infant intestinal microbiota", PLoS Biol, 5, pp.e177~ (2007)
  35. Hansen CH, "Patterns of early gut colonization shape future immune responses of the host", PLoS One, 7, pp.e34043~ (2012)
  36. Smith K, "Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota", Semin Immunol, 19, pp.59~69 (2007)
  37. He B, "Intestinal bacteria trigger T cell-independent immunoglobulin A(2)class switching by inducing epithelial-cell secretion of the cytokine APRIL", Immunity, 26, pp.812~826 (2007)
  38. Suzuki K, "The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut", Immunity, 33, pp.71~83 (2010)
  39. Wu HJ, "The role of gut microbiota in immune homeostasis and autoimmunity", Gut Microbes, 3, pp.4~14 (2012)
  40. Miyake S, "Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters", PLoS One, 10, pp.e0137429~ (2015)
  41. Farrokhi V, "Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis", Clin Transl Immunology, 2, pp.e8~ (2013)
  42. van Nimwegen FA, "Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy", J Allergy Clin Immunol, 128, pp.948~955 (2011)
  43. Penders J, "Gut microbiota composition and development of atopic manifestations in infancy : the KOALA Birth Cohort Study", Gut, 56, pp.661~667 (2007)
  44. Arrieta MC, "The intestinal microbiome in early life : health and disease", Front Immunol, 5, pp.427~ (2014)
  45. Watanabe S, "Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects", J Allergy Clin Immunol, 111, pp.587~591 (2003)
  46. Fieten KB, "Fecal microbiome and food allergy in pediatric atopic dermatitis : a cross-sectional pilot study", Int Arch Allergy Immunol, 175, pp.77~84 (2018)
  47. Geuking MB, "Intestinal bacterial colonization induces mutualistic regulatory T cell responses", Immunity, 34, pp.794~806 (2011)
  48. Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
  49. Song H, "Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis", J Allergy Clin Immunol, 137, pp.852~860 (2016)
  50. 김하정, "Clinical efficacy and mechanism of probiotics in allergic diseases", Clinical and Experimental Pediatrics, 56(9), pp.369~376 (2013), 대한소아청소년과학회
  51. Haahtela T, "The biodiversity hypothesis and allergic disease : world allergy organization position statement", World Allergy Organ J, 6, pp.3~ (2013)
  52. Marrs T, "The role of skin and gut microbiota in the development of atopic eczema", Br J Dermatol, 175(Suppl 2), pp.13~18 (2016)
  53. Mack DR, "Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression", Am J Physiol, 276, pp.G941~G950 (1999)
  54. Ramakrishna BS, "Probiotic-induced changes in the intestinal epithelium : implications in gastrointestinal disease", Trop Gastroenterol, 30, pp.76~85 (2009)
  55. Lin CS, "Impact of the gut microbiota, prebiotics, and probiotics on human health and disease", Biomed J, 37, pp.259~268 (2014)
  56. Nermes M, "Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis", Clin Exp Allergy, 41, pp.370~377 (2011)
  57. Zákostelská Z, "Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response", PLoS One, 11, pp.e0159539~ (2016)
  58. Lin YK, "Using imiquimod-induced psoriasis-like skin as a model to measure the skin penetration of anti-psoriatic drugs", PLoS One, 10, pp.e0137890~ (2015)
  59. Tan L, "The Akkermansia muciniphila is a gut microbiota signature in psoriasis", Exp Dermatol, 27, pp.144~149 (2018)
  60. Hidalgo-Cantabrana C, "Gut microbiota dysbiosis in a cohort of patients with psoriasis", Br J Dermatol, 181, pp.1287~1295 (2019)
  61. Shapiro J, "Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls", J Dermatol, 46, pp.595~603 (2019)
  62. Codoñer FM, "Gut microbial composition in patients with psoriasis", Sci Rep, 8, pp.3812~ (2018)
  63. Two AM, "Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors", J Am Acad Dermatol, 72, pp.749~758 (2015)
  64. Koçak M, "Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study", Dermatology, 205, pp.265~270 (2002)
  65. Dahl MV, "Temperature regulates bacterial protein production : possible role in rosacea", J Am Acad Dermatol, 50, pp.266~272 (2004)
  66. Yamasaki K, "Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea", Nat Med, 13, pp.975~980 (2007)
  67. Parodi A, "Small intestinal bacterial overgrowth in rosacea : clinical effectiveness of its eradication", Clin Gastroenterol Hepatol, 6, pp.759~764 (2008)
  68. Baran E, "The fungal flora of the digestive tract in patients with acne rosacea", Mykosen, 21, pp.277~284 (1978)
  69. Nam JH, "Rosacea and its association with enteral microbiota in Korean females", Exp Dermatol, 27, pp.37~42 (2018)

관련 논문AI추천

이 간행물의 다른 논문 (14건)